Combined with bioinformatics analysis, we hypothesized that the loss of ACADS regulates the metabolism of tumor-associated macrophages and promotes M2 macrophage polarization, resulting in antitumor immunity to promote the occurrence and development of CRC. The gene discussed is ACADS; the disease is colorectal carcinoma.